11Dec/13

Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS … – GlobeNewswire (press release)

Veloxis Pharmaceuticals Announces Initiation of ASERTAA Study of ENVARSUS
GlobeNewswire (press release)
Veloxis Pharmaceuticals A/S (OMX: VELO) today announced dosing of the first patient in ASERTAA (A Study of Extended Release Tacrolimus in African-Americans) Phase IIIb study of ENVARSUS® (formerly LCP Tacro™) in kidney transplant recipients.

and more »

09Dec/13

Glenmark launches generic Hydrocortisone Butyrate cream in US – Economic Times


Economic Times

Glenmark launches generic Hydrocortisone Butyrate cream in US
Economic Times
NEW DELHI: Glenmark Pharmaceuticals today said its US arm has launched the generic Hydrocortisone Butyrate cream used for treating various skin conditions in the American market and is entitled to 180 days exclusivity. “Glenmark Generics Inc, USA, the 
Glenmark launches hydrocortisone butyrate cream in USpharmabiz.com
Glenmark Launches Hydrocortisone Butyrate Cream In US MarketRTT News
Glenmark launches anti-inflammatory cream in USHindu Business Line

all 10 news articles »

08Dec/13

Glenmark – Glenmark announces launch of Hydrocortisone Butyrate cream in the … – Moneycontrol.com

Glenmark – Glenmark announces launch of Hydrocortisone Butyrate cream in the
Moneycontrol.com
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated December 09, 2013, titled “Glenmark announces launch of Hydrocortisone Butyrate cream in the US”. Glenmark Generic INC., USA, the subsidiary of Glenmark Generic,